Eugia Pharma Specialities Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit - 2, A-1128 & B-1127, RIICO Industrial Area, Phase-III, Bhiwadi, Rajasthan 301019, India (IND)
- Operations here
- analysisapi manufacturemanufacturepack
- FDA identifiers
- FEI 3009883410 · DUNS 864425497
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 2 drugs. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2025-11-14
- OAIDrug Quality Assurance2024-05-03
- VAIDrug Quality Assurance2022-06-24
- VAIDrug Quality Assurance2019-01-18
- VAIDrug Quality Assurance2018-03-06
- VAIDrug Quality Assurance2015-09-25
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.